MedAdvisor restructures
LISTED medication compliance technology provider, MedAdvisor, has announced a revamped senior executive team, including the departure of GM of Strategy, Simon Chamberlain after almost four years in the role (PD 13 Oct 2016).
CEO Robert Read said “we have spent the last few years establishing the foundations for MedAdvisor’s diversified global growth strategy.
“MedAdvisor has matured as a business over this time and now requires an elevated skill-set to deliver operational discipline to scale and execute in order to achieve investor expectations,” Read said.
The new team reporting to Read includes Chief Financial Officer, Simon Glover, Executive GM of People and Culture, Ruba ElAfifi, Company Secretary, Carlo Campiciano, and Chief Revenue Officer (CRO), Steve Watt.
“I’m confident that this team of executives demonstrate the capabilities needed to drive growth and operational excellence.”
Read also confirmed the departure of Chief Technology Officer (CTO), Victor Kovalev, who next month will relocate to the US to live with his family.
The interim CTO role will be filled by MedAdvisor’s Head of Architecture, Craig Shnuriger, who was one of the original founding members of the team.
Campiciano will retire later this year, with hiring efforts for his replacement already under way, while CRO Watt has also strengthened his team with several experts hired to run key functions such as marketing and PR.
“Hiring a world-class team to help drive MedAdvisor’s global growth is a key strategic pillar for the coming financial year,” Read said.
“As we scale for the next phase of growth, the team we need to help us achieve our targets looks very different...we now have a more senior executive team to help the business further mature, supported by more specialised expertise as we go deeper into various functions like sales and marketing.
“These changes provide clarity within the organisation and help us execute on our go-to-market strategy,” the CEO added.
MedAdvisor also recently added former Xero MD Chris Ridd and Jeff Sherman to its Board, while Read thanked the departing Kovalev and Chamberlain for their contributions.